IP Library Granted Patent US 9,663,552
Granted Patent B2
US 9,663,552 · App. 14/122,707 · Granted May 30, 2017

Purification method for proteins, in particular antibodies, utilizing a wash solution comprising arginine at high pH for the affinity chromatography step

Inventor: Achim Frauenschuh (Werentzhouse, FR)
Assignee: Novartis AG
C07K1/22
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,663,552
App. No.
14/122,707
Granted
May 30, 2017
Kind
B2
Abstract

The invention provides a washing method for affinity chromatography in which a wash solution comprising arginine, or an arginine derivative, at pH greater than 8.0, is effective in removing impurities without the presence of a nonbuffering salt, while simultaneously increasing product concentration in the eluate and maintaining a high percent yield of recovered product.

Claims (21)

1. A method of producing a purified protein of interest using an affinity chromatography (AC) matrix to which the protein of interest is bound, the method comprising washing the AC matrix with a wash solution comprising arginine, or an arginine derivative, at a pH of at least 8.5, and thereafter eluting the protein of interest from the AC matrix, wherein the wash is performed without the presence of a nonbuffering salt.

2. The method of claim 1 , wherein the method comprises:

a) loading a mixture comprising the protein of interest onto the AC matrix;

b) washing the AC matrix with a wash solution comprising arginine, or an arginine derivative, at a pH at least 8.5; and

c) eluting the protein of interest from the AC matrix,

wherein the wash is performed without the presence of a nonbuffering salt.

3. The method of claim 1 , wherein the protein of interest is an antibody, antibody fragment, or Fc fusion protein.

4. The method of claim 3 , wherein the AC matrix is a Protein A column.

5. The method of claim 1 , wherein the pH is 8.5-9.5.

6. The method of claim 1 , wherein the pH is about 8.9-9.0.

7. The method of claim 1 , wherein the pH is 9.0 or about 9.0.

8. The method of claim 1 , wherein the arginine derivative is selected from the group consisting of acetyl arginine, agmatine, arginic acid, N-alpha-butyroyl-L-argimine and N-alpha-pyvaloyl argimine.

9. The method of claim 1 , wherein arginine is at a concentration in a range of 0.1-0.5 M.

10. The method of claim 9 , wherein arginine is at a concentration of or about 0.25 M.

11. The method of claim 1 , wherein the wash solution comprises arginine-HCl.

12. A method of producing a purified antibody, antibody fragment, or Fc fusion protein using a Protein A column, the method comprising

a. loading a mixture comprising the antibody, antibody fragment, or Fc fusion protein onto the Protein A column;

b. washing the Protein A column with a wash solution comprising arginine, or an arginine derivative, at a pH at least 8.5; and

c. eluting the antibody, antibody fragment, or Fc fusion protein from the Protein A column,

wherein the wash is performed without the presence of a nonbuffering salt.

13. The method of claim 12 , further comprising equilibrating the Protein A column with an equilibration buffer prior to loading and/or eluting the antibody, antibody fragment, or Fc fusion protein from the Protein A column.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 28, 2014
From: FRAUNSCHUH, ACHIM
To: NOVARTIS PHARMA AG
Reel/Frame 032319/0328 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 28, 2014
From: NOVARTIS PHARMA AG
To: NOVARTIS AG
Reel/Frame 032319/0351 →
Continuity (2)
Provisional Application 61492092 · Jun 1, 2011
Related Publication 20140094593A1 · Apr 3, 2014